Cargando…
Treatment Response of Patients with Erythrodermic Psoriasis after Switching to Guselkumab
INTRODUCTION: Erythrodermic psoriasis (EP) is a rare variant of psoriasis. Due to its rarity, evidence supporting its treatment is limited. Patients with erythrodermic psoriasis often respond less favorably to conventional treatment and have lower biologic drug survival compared with patients with p...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Healthcare
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7858723/ https://www.ncbi.nlm.nih.gov/pubmed/33400156 http://dx.doi.org/10.1007/s13555-020-00480-x |